Abstract:Background A few reports have suggested chromosomal and gene expression abnormalities in mesenchymal stem cells in patients with MDS. Recently years, there is growing evidence for a role of the non-coding RNA in the transcriptional control of gene expression. Characterization of protein-coding and non-coding RNA expression in mesenchymal stem cells of MDS patients could be strategic for understanding gene expression regulation and role of marrow microenvironment in the pathophysiology of MDS. Methods In this study, gene expression profiles of MSC in 10 patients with MDS were compared with 5 healthy individuals using human transcriptome array. This array allows comprehensive examination of gene expression and noncoding transcripts, as well as detection of coding SNPs and genome-wide identification of alternative splicing. Real-time RT-PCR was performed to confirm the expression levels of selected transcripts. Results In MSC of MDS patients, 2628 genes were significantly differentially expressed (p≤0.01) in comparison to healthy individuals, of which 945(36%) were protein-coding transcripts. Gene ontology and pathway analysis were performed on those protein-coding genes. The significant significant ontology themes for up-regulated gene in MDS include cell division, mitosis, DNA repair and regulation of transcription, and for down-regulated genes include cytokine-mediated signaling pathway, inflammatory response and positive regulation of mitosis. Pathway analysis identified the deregulated gene pathway were main associated with purine metabolism, cytokine-cytokine receptor interaction, toll-like receptor signaling pathway, and so on. In non-coding RNA, 79 were long noncoding RNA (LncRNA), which were reported in database. We used gene coexpression networks to cluster thousands of transcripts into phenotypically relevant coexpression modules. The coexpression patterns of lncRNAs and protein-coding RNAs in MDS and controls were different. In the MDS coexpression network, differentially expressed lncRNAs were mainly focused on gene function related to ribosome biogenesis, tRNA processing, and so on. Conclusions These results demonstrated the differential RNA expression profile between MDS and healthy individuals, suggesting that lncRNAs may play an important role in dysfunctional microenvironment in MDS. Disclosures: No relevant conflicts of interest to declare.

Discovering Transcription and Splicing Networks in Myelodysplastic Syndromes

Distinct Splicing Signatures Affect Converged Pathways in Myelodysplastic Syndrome Patients Carrying Mutations in Different Splicing Regulators.

Clinical presentation and differential splicing of SRSF2, U2AF1 and SF3B1 mutations in patients with acute myeloid leukemia

An Integrated Regulatory Network Based on Comprehensive Analysis of mRNA Expression, Gene Methylation and Expression of Long Non-coding RNAs (lncRNAs) in Myelodysplastic Syndromes

Integrative Analysis of Next Generation Sequencing for Small Non-Coding RNAs and Transcriptional Regulation in Myelodysplastic Syndromes

Co-expression Networks Uncover Regulation of Splicing and Transcription Markers of Disease.

Roles of Alternative Splicing in Modulating Transcriptional Regulation

The Network Properties of Myelodysplastic Syndromes Pathogenesis Revealed by an Integrative Systems Biological Method

RUNX1 Deficiency Cooperates with SRSF2 Mutation to Further Disrupt RNA Splicing and Exacerbate Myelodysplastic Syndromes in Mouse Models

Systematic Characterization of Splicing Dysregulation in Pan Solid Tumor Transcriptome

Disease-associated mutation in SRSF2 misregulates splicing by altering RNA-binding affinities

Mutated Genes and Driver Pathways Involved in Myelodysplastic Syndromes-A Transcriptome Sequencing Based Approach

Single-cell transcriptome analyses reveal critical roles of RNA splicing during leukemia progression

Microarray Analysis of Differentially Expressed Micrornas in Myelodysplastic Syndromes.

Integrated analysis on mRNA microarray and microRNA microarray to screen immune-related biomarkers and pathways in myelodysplastic syndrome

Deregulated microRNA expression and its pathogenetic implications for myelodysplastic syndromes

Integrated Analysis of a Compendium of RNA-Seq Datasets for Splicing Factors.

Modulation of Transcriptional Activity in Brain Lower Grade Glioma by Alternative Splicing

Splicing factor-mediated regulation patterns reveals biological characteristics and aid in predicting prognosis in acute myeloid leukemia

Identification of Novel Therapeutic Targets in Myelodysplastic Syndrome Using Protein-Protein Interaction Approach and Neural Networks

Protein-Coding and Non-Coding RNA Expression Profiles of Mesenchymal Stem Cells in Patients with Myelodysplastic Syndromes